ClearPoint Neuro, Inc.
CLPTNASDAQHealthcare● Active
$13.46
+$0.57(+4.38%)
Market Cap$403509570
P/E Ratio—
52W High$30.1
52W Low$8.27
ClearPoint Neuro, Inc. (CLPT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CLPT · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $36.97M | $31.39M | $23.95M | $20.55M | $16.30M |
| Cost of Revenue | $14.28M | $12.27M | $10.34M | $7.02M | $5.18M |
| Gross Profit | $22.69M | $19.12M | $13.61M | $13.53M | $11.12M |
| Gross Margin %(computed) | 61.38% | 60.92% | 56.83% | 65.84% | 68.24% |
| Operating Expenses | |||||
| R&D Expenses | $13.90M | $12.39M | $11.71M | $10.89M | $9.28M |
| G&A Expenses | $16.50M | $12.00M | $11.76M | $9.61M | $8.00M |
| Total Operating Expenses | $46.86M | $38.87M | $36.06M | $29.86M | $24.50M |
| Operating Income | ($24.16M) | ($19.75M) | ($22.45M) | ($16.33M) | ($13.37M) |
| Operating Margin %(computed) | -65.36% | -62.91% | -93.70% | -79.47% | -82.05% |
| Interest Income | $1.21M | $0.87M | $0.39M | $0.00M | $0.00M |
| Interest Expense | $2.39M | $0.00M | $0.00M | $0.08M | $0.97M |
| Income Before Tax | ($25.48M) | ($18.91M) | ($22.09M) | ($16.43M) | ($14.41M) |
| Income Tax Expense | $0.06M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($25.54M) | ($18.91M) | ($22.09M) | ($16.43M) | ($14.41M) |
| Net Margin %(computed) | -69.08% | -60.25% | -92.21% | -79.97% | -88.41% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.90 | $-0.70 | $-0.90 | $-0.68 | $-0.69 |
| Wtd Avg Shares | 28.32M | 27.03M | 24.61M | 24.18M | 20.73M |
| EBITDA | ($21.93M) | ($17.84M) | ($20.99M) | ($15.58M) | ($12.74M) |
| EBITDA Margin %(computed) | -59.31% | -56.84% | -87.62% | -75.80% | -78.19% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more ClearPoint Neuro, Inc. data
About ClearPoint Neuro, Inc. (CLPT) Income Statement
ClearPoint Neuro, Inc. (CLPT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CLPT reported revenue of $0.04B, gross profit of $0.02B (gross margin 61.38%), and net income of ($0.03B) — a net profit margin of -69.08%.
Frequently asked questions
CLPT · 4 questionsClearPoint Neuro, Inc. (CLPT) reported revenue of $0.04B for 2025, up 17.8% year-over-year.
CLPT revenueCLPT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08